IDH1 and astrocytoma (excluding glioblastoma): After the evaluation of CDKN2A status, the WHO CNS grade of 10 cases (2 grade II cases, 8 grade III cases) that harbored CDKN2A HD were changed to WHO CNS grade 4 IDH-mutant astrocytoma in accordance with WHO CNS 2021.